Chapter 12

Perspective from a Pharmacoepidemiologist

Thomas K. Hazlet PharmD, DrPH

Thomas K. Hazlet PharmD, DrPH

Associate Professor

Pharmaceutical Outcomes Research and Policy Program, University of Washington, Department of Pharmacy, Room H-375, Health Sciences Center Box 357630, Seattle, WA 98195-7630, USA

Search for more papers by this author
First published: 02 March 2007

Summary

This chapter contains sections titled:

  • Introduction

  • Review of literature

  • Contrasts with pharmacopeidemiology

  • Conclusions

  • References

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.